TITLE

Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease

AUTHOR(S)
Roberts, G W; Gentleman, S M; Lynch, A; Murray, L; Landon, M; Graham, D I
PUB. DATE
April 1994
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Apr1994, Vol. 57 Issue 4, p419
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
66027738

 

Related Articles

  • Alzheimer's disease and the beta amyloid gene. Harrison, Paul J. // BMJ: British Medical Journal (International Edition);6/22/91, Vol. 302 Issue 6791, p1478 

    Focuses on the implication of beta amyloid precursor protein and gene in the pathogenesis of Alzheimer's disease. Identification of a peptide derivative of the beta amyloid protein in the vascular amyloid deposits and pathognomonic of the disease; Linkage of familial Alzheimer's disease to...

  • Traumatic brain injury: cause or risk of Alzheimer’s disease? A review of experimental studies. Szczygielski, J.; Mautes, A.; Steudel, W. I.; Falkai, P.; Bayer, T. A.; Wirths, O. // Journal of Neural Transmission;Nov2005, Vol. 112 Issue 11, p1547 

    Traumatic Brain Injury is the leading cause of death and disability among young individuals in our society. Moreover, according to some epidemiological studies, head trauma is one of the most potent environmental risk factors for subsequent development of Alzheimer’s disease....

  • Stroke, head injury can increase Alzheimer's risk.  // Pharmacy Today;Jul2007, Vol. 13 Issue 7, p1 

    The article studies the increased risk of Alzheimer's disease following a stroke or head injury in the U.S. The results indicate that the death of the brain cells causes the build-up of amyloid-beta protein, which is the main component of senile plaques present in the brains of patients with...

  • Vaccines for Alzheimer's disease: how close are we? Janus, Christopher // CNS Drugs;2003, Vol. 17 Issue 7, p457 

    Alzheimer’s disease is a neurodegenerative disorder characterised by a progressive loss of cognitive function. Despite the considerable progress being made, a complete description of the molecular pathology of this disease has yet to be elucidated. The evidence indicates that abnormal...

  • Mice found not to have Alzheimer's disease. Cherfas, Jeremy // BMJ: British Medical Journal (International Edition);3/21/92, Vol. 304 Issue 6829, p734 

    Reports the absence of Alzheimer's disease among mice. Effect of beta amyloid protein in the brain structure; Physiological effect of the model developed by Shigeki Kawabata; Implications of the histological finding to the characteristics similar in Alzheimer's disease.

  • Drug destroys plaques in many brain diseases.  // New Scientist;7/25/2015, Vol. 227 Issue 3031, p7 

    The article discusses a drug developed by researchers from NeuroPhage Pharmaceuticals in Cambridge, Massachusetts that targets and destroys plaques implicated in brain diseases such as Alzheimer's, Parkinson's and Creutzfeldt-Jakob disease (CJD). Topics include the drug's reduction of protein...

  • Amyloid Beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Janus, Christopher; Pearson, Jacqueline; McLaurin, JoAnne; Mathews, Paul M.; Jiang, Ying; Schmidt, Stephen D.; Chishti, M. Azhar; Horne, Patrick; Heslin, Donna; French, Janet; Mount, Howard T.J.; Nixon, Ralph A.; Mercken, Marc; Bergeron, Catherine; Fraser, Paul E.; St. George-Hyslop, Peter; Westaway, David // Nature;12/21/2000-12/28/2000, Vol. 408 Issue 6815, p979 

    Shows that amyloid beta immunization reduces both deposition of cerebral fibrillar amyloid beta and cognitive dysfunction in the TgCRND8 murine model of Alzheimer's disease without altering total levels of amyloid beta in the brain. Implication that either a fifty percent reduction in...

  • Amyloid has new role in Alzheimer's disease. Boulton, Alison // BMJ: British Medical Journal (International Edition);3/23/96, Vol. 312 Issue 7033, p728 

    Reports that British researchers investigating the protein beta amyloid which is deposited in the brain in Alzheimer's disease have shown its role in vascular damages. Damage of amyloid beta-proteins in the endothelial cells that line the blood vessels; Prevention by superoxide dismutase;...

  • Brain Stimulation Across Lifespan May Reduce Dementia.  // IDEA Fitness Journal;Jun2012, Vol. 9 Issue 6, p82 

    The article discusses engaging people in mentally stimulating activities over a lifetime to prevent the Alzheimer's disease. It mentions that the buildup of a protein in the brain is associated with Alzheimer's disease and to identify beta-amyloid deposits in healthy older adult's positron...

  • Nature: Scientists gain new understanding of Alzheimer's trigger.  // Biomedical Market Newsletter;5/7/2012, Vol. 21, p1 

    The article reports on the discovery of the existence of a protein which is a toxic beta-amyloid in the brains of the patients suffering from Alzheimer's disease.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics